Oaktree Specialty [OCSL] vs BlackRock [BLK] Detailed Stock Comparison
Oaktree Specialty
NASDAQ
Loading...
BlackRock
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Oaktree Specialty wins in 10 metrics, BlackRock wins in 8 metrics, with 0 ties. Oaktree Specialty appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Oaktree Specialty | BlackRock | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.09 | 27.48 | Oaktree Specialty |
| Price-to-Book Ratio | 0.82 | 3.58 | Oaktree Specialty |
| Debt-to-Equity Ratio | 99.18 | 28.51 | BlackRock |
| PEG Ratio | 0.01 | 12.58 | Oaktree Specialty |
| EV/EBITDA | N/A | 21.40 | N/A |
| Profit Margin (TTM) | 13.85% | 29.69% | BlackRock |
| Operating Margin (TTM) | 85.74% | 34.23% | Oaktree Specialty |
| EBITDA Margin (TTM) | 85.74% | 34.23% | Oaktree Specialty |
| Return on Equity | 3.11% | 13.92% | BlackRock |
| Return on Assets (TTM) | 5.64% | 3.61% | Oaktree Specialty |
| Free Cash Flow (TTM) | $19.08M | $4.70B | BlackRock |
| Dividend Yield | 17.76% | 1.58% | Oaktree Specialty |
| 1-Year Return | -19.33% | 27.82% | BlackRock |
| Price-to-Sales Ratio (TTM) | 3.62 | 8.16 | Oaktree Specialty |
| Enterprise Value | $2.59B | $183.34B | BlackRock |
| EV/Revenue Ratio | 7.75 | 8.50 | Oaktree Specialty |
| Gross Profit Margin (TTM) | N/A | 47.87% | N/A |
| Revenue per Share (TTM) | $4 | $141 | BlackRock |
| Earnings per Share (Diluted) | $0.57 | $41.35 | BlackRock |
| Beta (Stock Volatility) | 0.75 | 1.43 | Oaktree Specialty |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Oaktree Specialty vs BlackRock Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Oaktree Specialty | 0.51% | 1.10% | -2.56% | -4.98% | -14.67% | -10.32% |
| BlackRock | -0.03% | -2.69% | 3.24% | 13.57% | 14.41% | 10.92% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Oaktree Specialty | -19.33% | -34.81% | -8.65% | -29.04% | 34.21% | 12.08% |
| BlackRock | 27.82% | 66.82% | 87.75% | 262.58% | 699.48% | 1,241.02% |
Performance & Financial Health Analysis: Oaktree Specialty vs BlackRock
| Metric | OCSL | BLK |
|---|---|---|
| Market Information | ||
| Market Cap | $1.21B | $175.93B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 669,376 | 490,640 |
| 90 Day Avg. Volume | 629,132 | 614,720 |
| Last Close | $13.73 | $1,128.11 |
| 52 Week Range | $12.50 - $17.16 | $773.74 - $1,171.89 |
| % from 52W High | -19.99% | -3.74% |
| All-Time High | $30.60 (Jul 07, 2014) | $1,163.52 (Aug 15, 2025) |
| % from All-Time High | -55.13% | -3.04% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.21% | 0.13% |
| Quarterly Earnings Growth | 33.24% | 0.07% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.30% |
| Operating Margin (TTM) | 0.86% | 0.34% |
| Return on Equity (TTM) | 0.03% | 0.14% |
| Debt to Equity (MRQ) | 99.18 | 28.51 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $16.76 | $317.55 |
| Cash per Share (MRQ) | $0.91 | $63.07 |
| Operating Cash Flow (TTM) | $322.55M | $4.24B |
| Levered Free Cash Flow (TTM) | $70.07M | $5.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | 17.76% | 1.58% |
| Last 12-Month Dividend | $2.39 | $15.41 |
Valuation & Enterprise Metrics Analysis: Oaktree Specialty vs BlackRock
| Metric | OCSL | BLK |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.09 | 27.48 |
| Forward P/E | 6.18 | 23.14 |
| PEG Ratio | 0.01 | 12.58 |
| Price to Sales (TTM) | 3.62 | 8.16 |
| Price to Book (MRQ) | 0.82 | 3.58 |
| Market Capitalization | ||
| Market Capitalization | $1.21B | $175.93B |
| Enterprise Value | $2.59B | $183.34B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.75 | 8.50 |
| Enterprise to EBITDA | N/A | 21.40 |
| Risk & Other Metrics | ||
| Beta | 0.75 | 1.43 |
| Book Value per Share (MRQ) | $16.76 | $317.55 |
Financial Statements Comparison: Oaktree Specialty vs BlackRock
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | OCSL | BLK |
|---|---|---|
| Revenue/Sales | $-40.19M | $5.28B |
| Cost of Goods Sold | N/A | $2.75B |
| Gross Profit | N/A | $2.53B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $1.79B |
| EBITDA | N/A | $2.15B |
| Pre-Tax Income | $-35.99M | $1.76B |
| Income Tax | $264,000 | $248.00M |
| Net Income (Profit) | $-36.25M | $1.52B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | OCSL | BLK |
|---|---|---|
| Cash & Equivalents | $97.84M | $7.75B |
| Total Current Assets | N/A | $20.01B |
| Total Current Liabilities | N/A | $1.62B |
| Long-Term Debt | $1.45B | $14.26B |
| Total Shareholders Equity | $1.48B | $50.19B |
| Retained Earnings | $-893.11M | $36.28B |
| Property, Plant & Equipment | N/A | $4.27B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | OCSL | BLK |
|---|---|---|
| Operating Cash Flow | $-6.86M | $-1.13B |
| Capital Expenditures | N/A | $-78.00M |
| Free Cash Flow | $62.00M | $-1.21B |
| Debt Repayment | $-640.00M | $-24.00M |
| Common Stock Repurchase | $-4.29M | $-657.00M |
Short Interest & Institutional Ownership Analysis
| Metric | OCSL | BLK |
|---|---|---|
| Shares Short | 1.44M | 1.51M |
| Short Ratio | 2.34 | 2.35 |
| Short % of Float | 0.02% | 0.01% |
| Average Daily Volume (10 Day) | 669,376 | 490,640 |
| Average Daily Volume (90 Day) | 629,132 | 614,720 |
| Shares Outstanding | 82.25M | 154.95M |
| Float Shares | N/A | 143.70M |
| % Held by Insiders | 0.00% | 0.02% |
| % Held by Institutions | 0.42% | 0.83% |
Dividend Analysis & Yield Comparison: Oaktree Specialty vs BlackRock
| Metric | OCSL | BLK |
|---|---|---|
| Last 12-Month Dividend | $2.39 | $15.41 |
| Last 12-Month Dividend Yield | 17.76% | 1.58% |
| 3-Year Avg Annual Dividend | $2.41 | $16.79 |
| 3-Year Avg Dividend Yield | 3.15% | 0.65% |
| 3-Year Total Dividends | $7.23 | $50.37 |
| Ex-Dividend Date | Sep 15, 2025 | Mar 07, 2025 |